Dextromethorphan attenuates NADPH oxidase-regulated glycogen synthase kinase 3 and NF-B activation and reduces nitric oxide production in group a streptococcal infection

Chia-Ling Chen, Miao-Huei Cheng, Chih-Feng Kuo, Yi-Lin Cheng, Ming-Han Li, Chih-Peng Chang, Jiunn-Jong Wu, Robert Anderson, Shuying Wang, Pei-Jane Tsai, Ching-Chuan Liu, Yee-Shin Lin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Group A Streptococcus (GAS) is an important human pathogen that causes a wide spectrum of diseases, including necrotizing fasciitis and streptococcal toxic shock syndrome. Dextromethorphan (DM), an antitussive drug, has been demonstrated to efficiently reduce inflammatory responses, thereby contributing to an increased survival rate of GAS-infected mice. However, the anti-inflammatory mechanisms underlying DM treatment in GAS infection remain unclear. DM is known to exert neuroprotective effects through an NADPH oxidase-dependent regulated process. In the present study, membrane translocation of NADPH oxidase subunit p47 phox and subsequent reactive oxygen species (ROS) generation induced by GAS infection were significantly inhibited via DM treatment in RAW264.7 murine macrophage cells. Further determination of proinflammatory mediators revealed that DM effectively suppressed inducible nitric oxide synthase (iNOS) expression and NO, tumor necrosis factor alpha, and interleukin-6 generation in GAS-infected RAW264.7 cells as well as in air-pouch-infiltrating cells from GAS/DM-treated mice. GAS infection caused AKT dephosphorylation, glycogen synthase kinase-3 (GSK-3) activation, and subsequent NF-B nuclear translocation, which were also markedly inhibited by treatment with DM and an NADPH oxidase inhibitor, diphenylene iodonium. These results suggest that DM attenuates GAS infection-induced overactive inflammation by inhibiting NADPH oxidase-mediated ROS production that leads to downregulation of the GSK-3/NF-B/NO signaling pathway.

Original languageEnglish
Article numbere02045-17
JournalAntimicrobial Agents and Chemotherapy
Volume62
Issue number6
Early online dateMar 26 2018
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

Dextromethorphan
Glycogen Synthase Kinase 3
Streptococcal Infections
NADPH Oxidase
Streptococcus
Nitric Oxide
Infection
Reactive Oxygen Species
Antitussive Agents
Necrotizing Fasciitis
Neuroprotective Agents
Nitric Oxide Synthase Type II
Septic Shock
Interleukin-6
Anti-Inflammatory Agents
Down-Regulation
Tumor Necrosis Factor-alpha
Macrophages
Air
Inflammation

Keywords

  • Dextromethorphan
  • Group A Streptococcus
  • Inflammation

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Dextromethorphan attenuates NADPH oxidase-regulated glycogen synthase kinase 3 and NF-B activation and reduces nitric oxide production in group a streptococcal infection. / Chen, Chia-Ling; Cheng, Miao-Huei; Kuo, Chih-Feng; Cheng, Yi-Lin; Li, Ming-Han; Chang, Chih-Peng; Wu, Jiunn-Jong; Anderson, Robert; Wang, Shuying; Tsai, Pei-Jane; Liu, Ching-Chuan; Lin, Yee-Shin.

In: Antimicrobial Agents and Chemotherapy, Vol. 62, No. 6, e02045-17, 01.06.2018.

Research output: Contribution to journalArticle

Chen, Chia-Ling ; Cheng, Miao-Huei ; Kuo, Chih-Feng ; Cheng, Yi-Lin ; Li, Ming-Han ; Chang, Chih-Peng ; Wu, Jiunn-Jong ; Anderson, Robert ; Wang, Shuying ; Tsai, Pei-Jane ; Liu, Ching-Chuan ; Lin, Yee-Shin. / Dextromethorphan attenuates NADPH oxidase-regulated glycogen synthase kinase 3 and NF-B activation and reduces nitric oxide production in group a streptococcal infection. In: Antimicrobial Agents and Chemotherapy. 2018 ; Vol. 62, No. 6.
@article{cc3f1daffdd24dcbb5ee32187ea7af48,
title = "Dextromethorphan attenuates NADPH oxidase-regulated glycogen synthase kinase 3 and NF-B activation and reduces nitric oxide production in group a streptococcal infection",
abstract = "Group A Streptococcus (GAS) is an important human pathogen that causes a wide spectrum of diseases, including necrotizing fasciitis and streptococcal toxic shock syndrome. Dextromethorphan (DM), an antitussive drug, has been demonstrated to efficiently reduce inflammatory responses, thereby contributing to an increased survival rate of GAS-infected mice. However, the anti-inflammatory mechanisms underlying DM treatment in GAS infection remain unclear. DM is known to exert neuroprotective effects through an NADPH oxidase-dependent regulated process. In the present study, membrane translocation of NADPH oxidase subunit p47 phox and subsequent reactive oxygen species (ROS) generation induced by GAS infection were significantly inhibited via DM treatment in RAW264.7 murine macrophage cells. Further determination of proinflammatory mediators revealed that DM effectively suppressed inducible nitric oxide synthase (iNOS) expression and NO, tumor necrosis factor alpha, and interleukin-6 generation in GAS-infected RAW264.7 cells as well as in air-pouch-infiltrating cells from GAS/DM-treated mice. GAS infection caused AKT dephosphorylation, glycogen synthase kinase-3 (GSK-3) activation, and subsequent NF-B nuclear translocation, which were also markedly inhibited by treatment with DM and an NADPH oxidase inhibitor, diphenylene iodonium. These results suggest that DM attenuates GAS infection-induced overactive inflammation by inhibiting NADPH oxidase-mediated ROS production that leads to downregulation of the GSK-3/NF-B/NO signaling pathway.",
keywords = "Dextromethorphan, Group A Streptococcus, Inflammation",
author = "Chia-Ling Chen and Miao-Huei Cheng and Chih-Feng Kuo and Yi-Lin Cheng and Ming-Han Li and Chih-Peng Chang and Jiunn-Jong Wu and Robert Anderson and Shuying Wang and Pei-Jane Tsai and Ching-Chuan Liu and Yee-Shin Lin",
note = "Copyright {\circledC} 2018 American Society for Microbiology.",
year = "2018",
month = "6",
day = "1",
doi = "10.1128/AAC.02045-17",
language = "English",
volume = "62",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Dextromethorphan attenuates NADPH oxidase-regulated glycogen synthase kinase 3 and NF-B activation and reduces nitric oxide production in group a streptococcal infection

AU - Chen, Chia-Ling

AU - Cheng, Miao-Huei

AU - Kuo, Chih-Feng

AU - Cheng, Yi-Lin

AU - Li, Ming-Han

AU - Chang, Chih-Peng

AU - Wu, Jiunn-Jong

AU - Anderson, Robert

AU - Wang, Shuying

AU - Tsai, Pei-Jane

AU - Liu, Ching-Chuan

AU - Lin, Yee-Shin

N1 - Copyright © 2018 American Society for Microbiology.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Group A Streptococcus (GAS) is an important human pathogen that causes a wide spectrum of diseases, including necrotizing fasciitis and streptococcal toxic shock syndrome. Dextromethorphan (DM), an antitussive drug, has been demonstrated to efficiently reduce inflammatory responses, thereby contributing to an increased survival rate of GAS-infected mice. However, the anti-inflammatory mechanisms underlying DM treatment in GAS infection remain unclear. DM is known to exert neuroprotective effects through an NADPH oxidase-dependent regulated process. In the present study, membrane translocation of NADPH oxidase subunit p47 phox and subsequent reactive oxygen species (ROS) generation induced by GAS infection were significantly inhibited via DM treatment in RAW264.7 murine macrophage cells. Further determination of proinflammatory mediators revealed that DM effectively suppressed inducible nitric oxide synthase (iNOS) expression and NO, tumor necrosis factor alpha, and interleukin-6 generation in GAS-infected RAW264.7 cells as well as in air-pouch-infiltrating cells from GAS/DM-treated mice. GAS infection caused AKT dephosphorylation, glycogen synthase kinase-3 (GSK-3) activation, and subsequent NF-B nuclear translocation, which were also markedly inhibited by treatment with DM and an NADPH oxidase inhibitor, diphenylene iodonium. These results suggest that DM attenuates GAS infection-induced overactive inflammation by inhibiting NADPH oxidase-mediated ROS production that leads to downregulation of the GSK-3/NF-B/NO signaling pathway.

AB - Group A Streptococcus (GAS) is an important human pathogen that causes a wide spectrum of diseases, including necrotizing fasciitis and streptococcal toxic shock syndrome. Dextromethorphan (DM), an antitussive drug, has been demonstrated to efficiently reduce inflammatory responses, thereby contributing to an increased survival rate of GAS-infected mice. However, the anti-inflammatory mechanisms underlying DM treatment in GAS infection remain unclear. DM is known to exert neuroprotective effects through an NADPH oxidase-dependent regulated process. In the present study, membrane translocation of NADPH oxidase subunit p47 phox and subsequent reactive oxygen species (ROS) generation induced by GAS infection were significantly inhibited via DM treatment in RAW264.7 murine macrophage cells. Further determination of proinflammatory mediators revealed that DM effectively suppressed inducible nitric oxide synthase (iNOS) expression and NO, tumor necrosis factor alpha, and interleukin-6 generation in GAS-infected RAW264.7 cells as well as in air-pouch-infiltrating cells from GAS/DM-treated mice. GAS infection caused AKT dephosphorylation, glycogen synthase kinase-3 (GSK-3) activation, and subsequent NF-B nuclear translocation, which were also markedly inhibited by treatment with DM and an NADPH oxidase inhibitor, diphenylene iodonium. These results suggest that DM attenuates GAS infection-induced overactive inflammation by inhibiting NADPH oxidase-mediated ROS production that leads to downregulation of the GSK-3/NF-B/NO signaling pathway.

KW - Dextromethorphan

KW - Group A Streptococcus

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=85047461017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047461017&partnerID=8YFLogxK

U2 - 10.1128/AAC.02045-17

DO - 10.1128/AAC.02045-17

M3 - Article

C2 - 29581121

VL - 62

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 6

M1 - e02045-17

ER -